Autonomix Medical, Inc. to Join Virtual Investor Webinar Organized by Ladenburg Thalmann & Co. Inc.
Webinar Announcement: Autonomix Medical, Inc. will host a virtual investor webinar on August 21, 2025, at 1:00 PM ET, featuring CEO Brad Hauser and moderated by Jeffrey S. Cohen from Ladenburg Thalmann.
Company Focus: Autonomix is dedicated to advancing precision nerve-targeted treatments through innovative medical technologies, including a catheter-based microchip sensing array for diagnosing and treating nervous system diseases.
Initial Applications: The company's technology aims to address pain management, particularly in pancreatic cancer, and has potential applications across various medical fields such as cardiology and chronic pain management.
Regulatory Status: The technology is currently investigational and has not yet received marketing clearance in the United States.
About the author




